← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2008Last known activity
Jan 20, 2025
Defunct as of Dec 31, 2015
Timeline
2000s
- Jan 1, 2000
Biotech Pharmaceutical Co., Ltd.— Founded
2010s
- Dec 31, 2015
Biotech Pharmaceutical Co., Ltd.— Defunct
Drugs by trial phase (21 distinct, 32 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (10 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Colorectal Neoplasms
- Esophageal Neoplasms
- Esophageal Squamous Cell Carcinoma
- Glioblastoma
- Glioma
- Hypopharyngeal Neoplasms
- Lung Neoplasms
- Nasopharyngeal Carcinoma
- Nasopharyngeal Neoplasms
- Neoplasms
- Oropharyngeal Neoplasms
- Pancreatic Neoplasms
- Psoriasis
- Squamous Cell Carcinoma of Head and Neck
- Uterine Cervical Neoplasms
Recent trials (32)
- NCT06781086Lead sponsorPhase 2Jan 20, 2025
- NCT06633055Lead sponsorPhase 1Oct 31, 2024
- NCT06343116Lead sponsorPhase 3Apr 30, 2024
- NCT06333821Lead sponsorPhase 3Apr 1, 2024
- NCT05978544Lead sponsorPhase 1Dec 31, 2023
- NCT05986162Lead sponsorPhase 1Dec 30, 2023
- NCT05978050Lead sponsorPhase 3Sep 1, 2023
- NCT05823675Lead sponsorPhase 1May 19, 2023
- NCT06879691Lead sponsorPhase 4May 15, 2021
- NCT04882462CollaboratorPhase 2May 1, 2021
- NCT04532229Lead sponsorPhase 2Oct 8, 2020
- NCT06781073Lead sponsorPhase 3Jul 6, 2017
- NCT02611700Lead sponsorPhase 3Nov 1, 2015
- NCT02293356Lead sponsorPhase 4Aug 1, 2015
- NCT02395016Lead sponsorPhase 3Mar 1, 2015
Details
- Founded
- Beijing, CN Jan 1, 2000
- Last known activity
- Jan 20, 2025